Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oxford Immunotec Global PLC (NASDAQ:OXFD)

13.98
Delayed Data
As of May 26
 -0.21 / -1.48%
Today’s Change
7.73
Today|||52-Week Range
16.13
-6.49%
Year-to-Date
No recent news for Oxford Immunotec Global PLC.

Today’s Trading

Previous close14.19
Today’s open14.03
Day’s range13.84 - 14.12
Volume123,599
Average volume (3 months)104,313
Market cap$325.3M
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)+10.71%
Earnings growth (this year)-14.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.11%
P/E ratio--
Price/Sales3.88
Price/Book4.40

Competitors

 Today’s
change
Today’s
% change
VCYTVeracyte Inc+0.13+1.63%
QTNTQuotient Ltd+0.09+1.20%
CLDXCelldex Therapeutics...-0.04-1.29%
CALACalithera Bioscience...+0.60+3.92%
Data as of 4:00pm ET, 05/26/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$86.1M
Annual profit (last year)-$22.3M
Net profit margin-25.96%

Profile

Sector
Health Technology
Industry
Medical Specialties
CEO &
Executive Class III Director
Peter James Wrighton-Smith
Chief Operations Officer
Peter Edwardson
Corporate headquarters
Abingdon, Oxfordshire

Forecasts